Dr. Bardgett studies various aspects of medical education and healthcare outcomes. He investigates effective methods for training doctors, such as the impact of podcasts created by medical trainees that help disseminate vital information to a wide audience. Additionally, he evaluates risk assessment strategies for serious conditions like upper gastrointestinal bleeding and malignant pleural mesothelioma, a type of lung cancer. By analyzing patient data, he aims to enhance treatment approaches and ultimately improve survival rates for these patients.
Key findings
The pilot medical education podcasts have garnered nearly 250,000 total plays, highlighting their reach and impact on doctor training.
In evaluating risk for upper gastrointestinal bleeding, the AIMS65 score predicted 30-day mortality with an accuracy of 0.87, compared to 0.70 for the Glasgow-Blatchford score.
Among 114 patients with malignant pleural mesothelioma, the average survival was 345 days, but patients with the sarcomatoid subtype survived only 125 days on average.
Frequently asked questions
Does Dr. Bardgett study gastrointestinal bleeding?
Yes, Dr. Bardgett studies risk assessment in acute non-variceal upper gastrointestinal bleeding and compares different scoring systems to improve patient outcomes.
What role do podcasts play in Dr. Bardgett's research?
Dr. Bardgett looks at how medical education podcasts created by trainees can enhance learning, communication skills, and make training more accessible.
Is Dr. Bardgett's work relevant to mesothelioma patients?
Yes, his research on survival rates and treatment outcomes for malignant pleural mesothelioma helps medical professionals understand how to improve care for these patients.
Publications in plain English
Lessons from the Royal College of Physicians of Edinburgh's trainee-led medical education podcasts.
2025
The journal of the Royal College of Physicians of Edinburgh
Graham CJ, Armstrong NJ, Holmes C, Grant P, Bardgett J +4 more
Plain English This study looked at podcasts created by doctors in training for their peers, which have been very popular, with nearly 250,000 total plays from listeners around the world. The podcasts provide valuable medical education and help the doctors involved by enhancing their teaching and communication skills. This is important because it makes high-quality education accessible to more doctors, ultimately benefiting patients and healthcare systems.
Who this helps: This helps resident doctors and their patients.
Plain English This study looked at two scoring systems, AIMS65 and Glasgow-Blatchford score (GBS), to assess the risk of death in patients with upper gastrointestinal bleeding not caused by varices. Researchers reviewed records of 328 patients and found that AIMS65 was better at predicting 30-day mortality (5.2% died) with a score of 0.87 compared to GBS's score of 0.70. GBS performed better for needing blood transfusions and high dependency unit admissions.
Who this helps: This helps doctors better assess patients with gastrointestinal bleeding to improve treatment and outcomes.
Survival from malignant mesothelioma: where are we now?
2015
The journal of the Royal College of Physicians of Edinburgh
Marshall AD, Bayes HK, Bardgett J, Wedderburn S, Kerr KM +1 more
Plain English This study looked at the survival rates of 114 patients with malignant pleural mesothelioma, a type of lung cancer linked to asbestos exposure, over a ten-year period. On average, patients survived about 345 days, but those with the sarcomatoid subtype had a much shorter average survival of just 125 days. The research found that patients who did not receive chemotherapy had worse outcomes, and factors like low albumin levels and high urea at diagnosis also indicated a poorer prognosis.
Who this helps: This information can help doctors better understand how to treat patients with mesothelioma and improve their survival chances.
Christopher J Graham Natasha J Armstrong Charlotte Holmes Perrin Grant Anda Bularga Hannah Preston Katherine Ralston Marilena Giannoudi Andrew J Palmer Francesca Moroni
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.